Bold Therapeutics to Participate in 2026 Metals in Medicine Gordon Research Conference

VANCOUVER, BC, June 22, 2026 /PRNewswire/ -- Bold Therapeutics, a clinical-stage biopharmaceutical company founded to develop and commercialize novel metallotherapeutics is headed to the prestigious 2026 Metals in Medicine Gordon Research Conference this week in Andover, New Hampshire....